Clinical trial
Pilot Study Evaluating the Uptake of [18F] F-GLN by PET/CT in Breast Cancer
NCT03863457 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study Evaluating the Uptake of [18F] F-GLN by PET/CT in Breast Cancer
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 5, 2019
- Completion date
- December 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer